The trademark application LIRABET was filed by Sun Pharmaceutical Industries Limited, a corporation established under the laws of the Republic of India (the "Applicant"). The application was published for oppositions on August 1, 2022, and still open for oppositions.
The application was filed in English (German was selected as the second language).